Skip to main content
Clinical Trials/CTRI/2021/11/037921
CTRI/2021/11/037921
Recruiting
Phase 2

A randomised controlled clinical study to evaluate the efficacy of Darviyadi Ointment with Betadine Ointment (10%) in the management of Dushta vrana (Infected Wound)

DR JANESH GUPTA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
DR JANESH GUPTA
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR JANESH GUPTA

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients having sign and symptoms of Dushta Vrana like: srava, gandha, daha, vedana, kandu.
  • 2\)Those who are willing and fulfill 2 out of 5 from the above criteria will be included.
  • 3\)Dushta vrana size maximum upto 5cm length and 5cm breadth.
  • 4\) Patients of controlled Hypertension on their regular medicines will be included.

Exclusion Criteria

  • 1\) Patients having Diabetes Mellitus, Septicemia and Anaemia (Hb \<10gm%).
  • 2\) The patients suffering from systemic diseaes such as Hepatitis\-B, Malignancy, Varicose ulcer, Deep vein thrombosis, Arterial ulcer, Neurogenic ulcer, Leprosy, Pregnancy, Leukemia.

Outcomes

Primary Outcomes

Not specified

Similar Trials